Page 134 - Pagetit
P. 134

4. PSYCHOPHARMACOLOGY OF DEPENDENCE FOR DIFFERENT DRUG CLASSES



                     Davis WM, Smith TE, Smith SG (1987) Intravenous and intragastric self-
                     administration of chlordiazepoxide in the rat. Alcohol and Drug Research, 7:511–
                     516.
                     De la Torre R et al. (2000) Non-linear pharmacokinetics of MDMA (‘ecstasy’) in
                     humans. British Journal of Clinical Pharmacology, 49:104–109.
                     Devane WA et al. (1988) Determination and characterization of cannabinoid
                     receptor in rat brain. Molecular Pharmacology, 34:605–613.
                     Devane WA et al. (1992) Isolation and structure of a brain constituent that binds
                     to the cannabinoid receptor. Science, 258:1946–1949.
                     Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related
                     to addiction. European Journal of Pharmacology, 393:295–314.
                     Di Chiara G, Imperato A (1988a) Drug abuse by humans preferentially increases
                     synaptic dopamine concentrations in the mesolimbic system of freely-moving
                     rats. Proceedings of the National Academy of Science of the United States of
                     America, 94:5274–5278.
                     Di Chiara G, Imperato A (1988b) Opposite effects of mu- and kappa-opiate
                     agonists on dopamine release in the nucleus accumbens and in the dorsal caudate
                     of freely-moving rats. Journal of Pharmacology and Experimental Therapeutics,
                     244:1067–1080.
                     Di Marzo V (1999) Biosynthesis and inactivation of endocannabinoids: relevance
                     to their proposed role as neuromodulators. Life Sciences, 65:645–655.
                     Di Marzo V et al. (1998) Endocannabinoids: endogenous cannabinoid receptor
                     ligands with neuromodulatory action. Trends in Neuroscience, 21:521–528.
                     Downing J (1986) The psychological and physiological effects of MDMA on normal
                     volunteers. Journal of Psychoactive Drugs, 18:335–340.
                     Evans AC, Raistrick D (1987) Phenomenology of intoxication with toluene-based
                     adhesives and butane gas. British Journal of Psychiatry, 150:769–773.
                     Evans EB, Balster RL (1991) CNS depressant effects of volatile organic solvents.
                     Neuroscience and Biobehavioral Reviews, 15:233–241.
                     Fadda F, Rossetti ZL (1998) Chronic ethanol consumption: from neuroadaptation
                     to neurodegeneration. Progress in Neurobiology, 56:385–431.
                     Farrell M et al. (2002) Methamphetamine: drug use and psychoses becomes a
                     major public health issue in the Asia-Pacific region. Addiction, 9:771–772.
                     Feigenbaum JJ, Yanai J (1983) Evidence for the involvement of central dopaminergic
                     receptors in the acute and chronic effects induced by barbiturates.
                     Neuropsychobiology, 9:83–87.
                     Fischer B et al. (2002) Heroin-assisted treatment as a response to the public health
                     problem of opiate dependence in established market economies: an overview.
                     European Journal of Public Health, 12:228-34.
                     Fischer G et al. (2000) Treatment of opioid-dependent pregnant women with
                     buprenorphine. Addiction, 95:239–244.
                     Foulds J et al. (1997) Mood and physiological effects of subcutaneous nicotine in
                     smokers and never-smokers. Drug and Alcohol Dependence, 44:105–115.


                                                     113




          Chapter_4                113                             19.1.2004, 11:43
   129   130   131   132   133   134   135   136   137   138   139